NASDAQ:OMTH - Omthera Pharmaceuticals Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Omthera Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Omthera Pharmaceuticals, Inc is a specialty pharmaceutical company. The Company is focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease. Epanova, its product candidate, is a late-stage, omega-three free fatty acid composition that reduces triglycerides, improves other key lipid parameters. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:OMTH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.omthera.com/ Phone+1-908-7414323Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive OMTH News and Ratings via Email Sign-up to receive the latest news and ratings for OMTH and its competitors with MarketBeat's FREE daily newsletter. Omthera Pharmaceuticals (NASDAQ:OMTH) Frequently Asked Questions What is Omthera Pharmaceuticals' stock symbol? Omthera Pharmaceuticals trades on the NASDAQ under the ticker symbol "OMTH." Has Omthera Pharmaceuticals been receiving favorable news coverage? Headlines about OMTH stock have been trending negative recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Omthera Pharmaceuticals earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Omthera Pharmaceuticals. What other stocks do shareholders of Omthera Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Omthera Pharmaceuticals investors own include Scorpio Tankers (STNG), Corcept Therapeutics (CORT), Ceragon Networks (CRNT), Cypress Semiconductor (CY), SmileDirectClub (SDC), Sunesis Pharmaceuticals (SNSS), Sarepta Therapeutics (SRPT), Xencor (XNCR), ExOne (XONE) and Aurora Cannabis (ACB). What is Omthera Pharmaceuticals' official website? The official website for Omthera Pharmaceuticals is http://www.omthera.com/. How can I contact Omthera Pharmaceuticals? Omthera Pharmaceuticals' mailing address is 707 State Rd, PRINCETON, NJ 08540-1438, United States. The specialty pharmaceutical company can be reached via phone at +1-908-7414323. MarketBeat Community Rating for Omthera Pharmaceuticals (NASDAQ OMTH)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 75 (Vote Outperform)Underperform Votes: 84 (Vote Underperform)Total Votes: 159MarketBeat's community ratings are surveys of what our community members think about Omthera Pharmaceuticals and other stocks. Vote "Outperform" if you believe OMTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMTH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/27/2020 by MarketBeat.com StaffFeatured Article: What is the Current Ratio?